Health Care Ticks Up After UnitedHealth Earnings — Health Care Roundup
Provided by
Dow Jones
Health-care companies rose after strong earnings from UnitedHealth Group alleviated fears about the impact of rising medical on health insurers.
The healthcare giant's first-quarter adjusted earnings topped Wall Street's estimates, despite a cyberattack that paralyzed national databases and weighed on earnings. The theft of medical data was perpetrated by a Russian gang known as ALPHV, or BlackCat.
Johnson & Johnson fell after the health-care conglomerate's earnings lagged some investors' expectations.
Shares of ProPhase Labs rallied after the biotech and diagnostic firm unveiled a new project that utilizes an AI platform and its massive genomics database.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
April 16, 2024 18:12 ET (22:12 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track